Abstract
Multiple sclerosis (MS) is the most common inflammatory, demyelinating, and neurodegenerative disorder of the central nervous system (CNS) in humans. Although the etiology of MS remains unknown, several lines of evidence support the notion that autoimmunity against components of the myelin sheath plays a major role in susceptibility to and development of the disease. At present, there are no approved MS therapies aimed specifically toward downregulating antigen-specific autoreactive immune cells. One antigen-specific approach that appears promising for the treatment of MS is DNA vaccination. This technique has demonstrated efficacy in clinical trials while maintaining safety.
Here, we describe the generation of DNA vaccines containing immunologically relevant antigens of MS. Moreover, we present a detailed protocol for the prophylactic and therapeutic administration of DNA vaccines via intramuscular injection targeting on the development of experimental autoimmune encephalomyelitis (EAE), an animal model resembling MS.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Frohman EM, Racke MK, Raine CS (2006) Multiple sclerosis–the plaque and its pathogenesis. N Engl J Med 354:942–955
Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683–747
Ferrera F, La Cava A, Rizzi M et al (2007) Gene vaccination for the induction of immune tolerance. Ann N Y Acad Sci 1110:99–111
Garren H, Steinman L (2000) DNA vaccination in the treatment of autoimmune disease. Curr Dir Autoimmun 2:203–216
Fissolo N, Montalban X, Comabella M (2012) DNA-based vaccines for multiple sclerosis: current status and future directions. Clin Immunol 142:76–83
Ho PP, Higgins JP, Kidd BA et al (2006) Tolerizing DNA vaccines for autoimmune arthritis. Autoimmunity 39:675–682
Prud’homme GJ, Draghia-Akli R, Wang Q (2007) Plasmid-based gene therapy of diabetes mellitus. Gene Ther 14:553–564
Zamvil SS, Steinman L (1990) The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 8:579–621
Friese MA, Montalban X, Willcox N et al (2006) The value of animal models for drug development in multiple sclerosis. Brain 129:1940–1952
Fritz RB, Chou CH, McFarlin DE (1983) Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J Immunol 130:1024–1026
Tuohy VK, Sobel RA, Lees MB (1988) Myelin proteolipid protein induced experimental allergic encephalomyelitis. Variations of disease expression in different strains of mice. J Immunol 140:1868–1873
Johns TG, Kerlero de Rosbo N, Menon KK et al (1995) Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol 154:5536–5541
Green MR, Sambrook J (2012) Molecular cloning: a laboratory manual, 4th edn. Cold Spring Harbor Laboratory Press, Spring Harbor, NY
Gold R, Linington C, Lassmann H (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129:1953–1971
Langrish CL, Chen Y, Blumenschein WM et al (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233–240
Olsson T (1992) Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma. J Neuroimmunol 40:211–218
Flecknell P (1996) Laboratory animal anaesthesia: a practical introduction for research workers and technicians. Academic, London
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Fissolo, N., Montalban, X., Comabella, M. (2014). DNA Vaccination Techniques. In: Weissert, R. (eds) Multiple Sclerosis. Methods in Molecular Biology, vol 1304. Humana Press, New York, NY. https://doi.org/10.1007/7651_2014_87
Download citation
DOI: https://doi.org/10.1007/7651_2014_87
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2629-9
Online ISBN: 978-1-4939-2630-5
eBook Packages: Springer Protocols